Literature DB >> 11825046

Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants.

P Gianino1, E Mastretta, P Longo, A Laccisaglia, M Sartore, R Russo, A Mazzaccara.   

Abstract

Rotavirus is one of the most important aetiological agents of nosocomial infections in childhood. We studied the incidence of nosocomial rotavirus infections in 420 patients (age range 1-18 months) consecutively admitted from 1 December 1999 to 31 May 2000 to the infant ward of the Department of Paediatrics, University of Turin. We also evaluated the protective effect of breast feeding. Faecal specimens were collected from every child (whether developing diarrhoeic symptoms or not) and tested for rotavirus during hospitalization and 72 h after discharge. The incidence of rotavirus nosocomial infections was 27.7%. The incidence of symptomatic nosocomial infections was 16.8%, and the incidence of asymptomatic infections was 10.9%. The attack rate of the infections that occurred during hospitalization was 11.8%, while for those occurring after discharge, it was 15.9%. Rotavirus infection, on average, prolonged hospital stay from 5.2 to 6.4 days. 10.6% of breast-fed infants and 32.4% of non-breast-fed infants contracted rotavirus infection (P<0.005). None of the breast-fed infants who contracted rotavirus infection developed diarrhoeic symptoms. Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2002        PMID: 11825046     DOI: 10.1053/jhin.2001.1129

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  6 in total

1.  The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis.

Authors:  Mark P Connolly; Oleksandr Topachevskyi; Baudouin Standaert; Omayra Ortega; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 2.  The paediatric burden of rotavirus disease in Europe.

Authors: 
Journal:  Epidemiol Infect       Date:  2006-04-04       Impact factor: 2.451

Review 3.  Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial.

Authors:  M Van der Wielen; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-20       Impact factor: 3.267

4.  Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study.

Authors:  Filippo Festini; Priscilla Cocchi; Daniela Mambretti; Bruna Tagliabue; Milena Carotti; Daniele Ciofi; Klaus P Biermann; Roberto Schiatti; Franco M Ruggeri; Fernando Maria De Benedictis; Alessandro Plebani; Alfredo Guarino; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2010-08-09       Impact factor: 3.090

5.  Nosocomial infection due to rotavirus in infants in Alzahra Hospital, Isfahan, Iran.

Authors:  Roghayeh Kordidarian; Roya Kelishadi; Yaaghob Arjmandfar
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

6.  Rotavirus Gastroenteritis in a Neonatal Unit of a Greek Tertiary Hospital: Clinical Characteristics and Genotypes.

Authors:  Dimitra Koukou; Panagiota Chatzichristou; Georgios Trimis; Tania Siahanidou; Anna-Venetia Skiathitou; Emmanouil I Koutouzis; George A Syrogiannopoulos; Athanasia Lourida; Athanasios G Michos; Vassiliki P Syriopoulou
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.